Location: Home
  • search
  • go
  • Relate News
  • 4/5/2025Recent Executive Moves
  • 4/5/2025China Biopharma Licensing Tracker, Q1 2025 (MC)
  • 4/5/2025China Biopharma Financing Tracker, Q1 2025 (MC)
  • 4/1/2025China's Pharma Industry Shows Signs of Recovery After Economic Downtur...
  • 4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
  • 4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
  • 3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
  • 3/31/2025BMS's Opdivo and Yervoy Combio Approved in China
  • 3/31/2025Roche's Ocrevus Receives Chinese Approval for MS
  • 3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib
  • 3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
  • 3/28/2025Recent Executive Moves
  • 3/27/2025Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)
  • 3/27/2025China to Spur Innovation through New Reimbursement List (ThePharmaLett...
  • 3/26/2025Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346
  • 3/26/2025NMPA Holds 2025 National Drug Regulatory Policy and Law Conference
  • 3/26/2025NMPA Issues Announcement on the Implementation of Chinese Pharmacopoei...
  • 3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
  • 3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...
  • 3/25/2025Eli Lilly Launches Lilly Gateway Laboratory in Beijing to Foster Innov...
  • 3/25/2025Merck Group to Expand in China with Focus on AI-Powered Precision Medi...
  • 3/25/2025China's BMI Fund Surpasses CNY16.5 Trillion with 11% Annual Growth
  • 3/25/2025Expedition Therapeutics Secures Seed Funding to Bridge Chinese Innovat...
  • 3/25/2025Growing Awareness and Expanding Treatment Options for Sleep Disorders ...
  • 3/25/2025Hengrui and Elevar Face Second FDA Rejection for Liver Cancer Combo Th...
  • 3/24/2025Elevation Oncology to Discontinue Development of CSPC-licensed EO-3021
  • 3/24/2025HBM Enters into Global Strategic Deal with AstraZeneca for Next-Gen Th...
  • 3/24/2025AstraZeneca Announces $2.5B Investment in China
  • 3/24/2025CDE Seeks Public Comments on Draft ICH M11 Clinical Protocol Template
  • 3/24/2025Heng Ren Partners Calls for $8.9B Cash Distribution from Sinovac and ...
  • Page:11/363 Total number of articles:10881: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group